Drug General Information (ID: DDIABSEDP0)
  Drug Name Zidovudine Drug Info Probenecid Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Anti-Hiv Agents Uricosuric Agents
  Structure

 Mechanism of Zidovudine-Probenecid Interaction (Severity Level: Moderate)
     Competitive inhibition of renal tubular secretion Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Zidovudine Probenecid
      Mechanism Zidovudine Inhibition of the renal tubular secretion of zidovudine
      Key Mechanism Factor 1
Factor Name Renal tubular secretion
Factor Description Renal tubular secretion allows selective transfer of substances from the blood around the capillaries into the renal tubules via filtrate. Drug excretion may be reduced when two drugs compete for renal tubular secretion.
      Mechanism Description
  • Decreased elimination of Zidovudine caused by Probenecid mediated competitive inhibition of renal tubular secretion

Recommended Action
      Management Patients should be monitored for signs of zidovudine toxicity (anemia, nausea, headache, myalgia, malaise, fever, or rash). Zidovudine dosage may need to be reduced, or the dosing interval may need to be lengthened.

References
1 Burger DM, Meenhorst PL, Koks CH, Beijnen JH "Drug interactions with zidovudine." AIDS 7 (1993): 445-60. [PMID: 8507410]
2 Kornhauser DM, Hendrix CW, Nerhood LJ, et al "Probenecid and zidovudine metabolism." Lancet 2 (1989): 473-5
3 de Miranda P, Good SS, Yarchoan R, et al "Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex." Clin Pharmacol Ther 46 (1989): 494-500